儿科神经炎症疾病:医院利用率和人口负担的模式
Alexander J Sandweiss1, Chau Truong2, Kristy O Murray3
1Department of Pediatrics, Division of Pediatric Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
Hospital pediatrics
|November 24, 2025
概括
儿科神经炎症性疾病 (NID) 导致昂贵的住院治疗,通常需要密集护理和更长的停留时间. 了解这种负担对于医疗保健资源分配和患者管理至关重要.
科学领域:
- 儿科神经学 儿科神经学
- 卫生经济学 卫生经济学
- 医疗保健管理的管理
背景情况:
- 儿科神经炎症性疾病 (NID) 是一个重要的,但未得到充分量化的医疗负担.
- 现有的数据缺乏对儿童NID相关住院治疗的综合性成本估计.
- 这些情况被怀疑会对医疗保健支出产生不成比例的影响.
研究的目的:
- 评估 NID 儿科住院病人的经济和资源利用负担.
- 在儿科NID病例中确定住院资源使用的关键驱动因素.
- 分析成本,停留时间和重症监护室 (ICU) 使用情况.
主要方法:
- 德克萨斯州医院行政数据 (2016-2023) 的分析.
- 包括针对特定NID的儿科住院情况:急性传播性脑筋炎,脑筋炎/脑筋炎 (E/EM),多发性硬化症/神经髓炎光学谱障碍,其他脱髓性疾病,急性横向髓炎和其他髓炎.
- 将费用转换为费用,使用医院特定的费用比率,膨胀到2023年的价值;为高成本,长期LOS和ICU入院进行统计建模.
主要成果:
- 总共有2155例儿科NID住院病例被确定,其中E/EM是最常见的诊断.
- 住院费用中位数为31,365.49美元,住院时间中位数为6天.
- 超过一半 (59.1%) 的住院病例涉及ICU入院,显著增加成本;诊断组预测高成本,长期LOS和ICU停留.
结论:
- 儿科NID给儿童带来了相当大的医疗负担,其特点是长时间住院,需要重症监护以及成本上升.
- 这些发现证实了关于这些条件的资源密集型性质的临床观察.
- 这项研究强调了需要更好地了解和管理儿童群体中NIDs的需要.
更多相关视频
07:01A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
845
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
21.0K
相关概念视频
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
247
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179